novo nordisk lawsuit semaglutide A Review of Nordisk's Ozempic and Wegovy Trademark Enforcement Campaign Novo is suing Hims &

M.CejudoF

Therapists trained in eating and body image concerns are skilled at recognizing early warning signs and helping you course-correct before patterns become longer lasting

GLP-1 medications are commonly used to treat obesity and diabetes

In most cases, well-organized dietary intake and consistent physical activity are essential for results that last

In such cases, the appetite-suppressing effects of GLP-1RAs could potentially exacerbate behaviors like dietary restriction and dietary restraint, two behavioral patterns that help sustain eating disorder psychopathology, thus complicating treatment for these disorders